Analysis of guiding value and effect of TEG in clinical application of cryoprecipitation
10.13303/j.cjbt.issn.1004-549x.2022.11.011
- VernacularTitle:血栓弹力图在冷沉淀使用中的指导价值及效果分析
- Author:
Jiafu HUANG
1
;
Meihong CHEN
1
;
Yaojian WU
1
Author Information
1. Department of Blood Transfusion, the 910 hospital, Quanhou 362000, China
- Publication Type:Journal Article
- Keywords:
cryoprecipitate;
fibrinogenopenia;
coagulation function;
thrombelastogram(TEG)
- From:
Chinese Journal of Blood Transfusion
2022;35(11):1135-1138
- CountryChina
- Language:Chinese
-
Abstract:
【Objective】 To retrospectively analyze the guiding significance and effect of thromboelogram (TEG) in the clinical use of cryoprecipitation. 【Methods】 A total of 289 patients with fibrinogen reduction, admitted to our hospital between January 2018 and December 2021, were collected. They was divided into control group (using coagulation examination and clinical feature as the transfusion criteria) and observation group (above parameters plus TEG). The TEG index in the observation group before and after transfusion and Fg, APTT, PT, and TT in 2 groups of patients before and after transfusion were monitored. The efficacy and prognosis of different blood products and cryoprecipitate were compared between 2 groups of patients.) 【Results】 The efficacy of choprecipitate transfusion was better in the observation group than the control[Fg index after transfusion (g / L) 1.92±0.92 vs 1.80±1.00, P<0.05]. And less blood products were used in observation group as compared with the control[ RBC(U) 1.93±2.69 vs 2.81±3.25 (P<0.05); FFP(mL) 667±378 vs 879±455(P<0.05)]. No differences were noticed by hospital stay between the two groups, but the prognosis in the observed group was significantly better than that in the control. 【Conclusion】 It’s scientific and reasonable to apply TEG to guide the clinical transfusion of cryoprecipitate, so as to save blood resources and improve the prognosis.
